Jay Meyer

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies

Stuart Stoloff, David A. Stempel, Jay Meyer et al. · Journal of Allergy and Clinical Immunology · 2004 · 247 citations · Full text

Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population.

Jennifer S. Schultz, John C. O’Donnell, Ken McDonough et al. · PubMed · 2005 · 107 citations

Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective

David W. Lee, Jay Meyer, Jon Clouse · Value in Health · 2001 · 48 citations · Full text

Disease Management, Healthcare Value, Health Economics +11

One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma

David A. Stempel, Jay Meyer, Richard H. Stanford et al. · Journal of Allergy and Clinical Immunology · 2001 · 38 citations

Asthma, Medicine, Allergen +6

Patterns and Effectiveness of Lipid-Lowering Therapies in a Managed Care Environment

Jay Meyer, Jennifer S. Schultz, John C. O’Donnell et al. · Value in Health · 2005 · 19 citations · Full text

Non-pharmacological Intervention, Lipid Disorder, Preventive Medicine +10